Neurology

Non-Pharmacological Approaches to Managing Patients With Alzheimer’s Disease
http://academiccme.com/wp-content/uploads/2017/12/AD-Image_-Module-3-wpcf_80x80.jpg
In this module of a Four-Part Expert Interview Series, Max Lugavere, along with Dr. Richard S. Isaacson, course chair, will explore non-pharmacological approaches to managing patients with Alzheimer’s disease (AD)…
Webcast
The Role of Beta-Amyloid and Tau: CSF Protein Levels and PET Imaging
http://academiccme.com/wp-content/uploads/2017/12/AD-Image_-Module-1-wpcf_80x80.jpg
In this module of a Four-Part Expert Interview Series, Dr. Barry W. Rovner, along with Dr. Richard S. Isaacson, course chair, will provide learners with an update regarding beta-amyloid and tau biomarkers and their role in Alzheimer’s disease (AD) pathology and progression…
Webcast
MSParis2017: Clinical Update of Emerging S1P Therapeutics for the Treatment of Multiple Sclerosis
http://academiccme.com/wp-content/uploads/2017/12/iStock-538262387-wpcf_80x80.jpg
This CME post conference review and analysis will feature content presented at the MS Paris 2017 7th Joint ECTRIMS-ACTRIMS Meeting in Paris, France…
Webcast, Post Conference Review and Analysis
The Role of Emerging Therapeutics to Reduce Impairment and Improve Quality of Life for Patients With Early Alzheimer’s Disease
http://academiccme.com/wp-content/uploads/2017/08/AD-Image-wpcf_80x80.jpg
This CME program will highlight content presented at the Alzheimer’s Association International Conference 2017 held in London, England…
Webcast
AAN 2017: Clinical Updates on Novel Receptor Modulator Therapeutics for the Management of Patients with Relapsing Multiple Sclerosis
http://academiccme.com/wp-content/uploads/2017/05/iStock-611992272-wpcf_80x80.jpg
This CME program will highlight recent scientific advances in the management and treatment of patients with relapsing multiple sclerosis presented at the American Academy of Neurology 2017 Annual Meeting in Boston, Massachusetts…
Post Conference Review and Analysis